Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica

被引:211
作者
Eaves, DJ
Randall, L
Gray, DT
Buckley, A
Woodward, MJ
White, AP
Piddock, LJV [1 ]
机构
[1] Univ Birmingham, Div Immun & Infect, Antimicrobial Agents Res Grp, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Stat Advisory Serv, Birmingham B15 2TT, W Midlands, England
[3] Vet Labs Agcy, Dept Food & Environm Safety, Surrey, England
关键词
D O I
10.1128/AAC.48.10.4012-4015.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Salmonella enterica isolates (n = 182) were examined for mutations in the quinolone resistance-determining region of gyrA, gyrB, parC, and parE. The frequency, location, and type of GyrA substitution varied with the serovar. Mutations were found in parC that encoded Thr57-Ser, Thr66-Ile, and Ser80-Arg substitutions. Mutations in the gyrB quinolone resistance-determining region were located at codon Tyr420-Cys or Arg437-Len. Novel mutations were also found in parE encoding Glu453-Gly, His461-Tyr, Ala498-Thr, Val512-Gly, and Ser518-Cys. Although it is counterintuitive, isolates with a mutation in both gyrA and parC were more susceptible to ciprofloxacin than were isolates with a mutation in gyrA alone.
引用
收藏
页码:4012 / 4015
页数:4
相关论文
共 16 条
  • [1] Is it time to change fluoroquinolone breakpoints for Salmonella spp.?
    Aarestrup, FM
    Wiuff, C
    Molbak, K
    Threlfall, EJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 827 - 829
  • [2] ANDERRSSON DL, 1998, LAKARTIDNINGEN, V95, P3943
  • [3] Andersson D I, 1998, Lakartidningen, V95, P3943
  • [4] Determination of minimum inhibitory concentrations
    Andrews, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 5 - 16
  • [5] Virulence of antibiotic-resistant Salmonella typhimurium
    Björkman, J
    Hughes, D
    Andersson, DI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) : 3949 - 3953
  • [6] Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography
    Eaves, DJ
    Liebana, E
    Woodward, MJ
    Piddock, LJV
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) : 4121 - 4125
  • [7] Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany
    Guerra, B
    Malorny, B
    Schroeter, A
    Helmuth, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) : 2059 - 2059
  • [8] Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro
    Hansen, H
    Heisig, P
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2003, 9 (01): : 25 - 32
  • [9] European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
    Kahlmeter, G
    Brown, DFJ
    Goldstein, FW
    MacGowan, AP
    Mouton, JW
    Österlund, A
    Rodloff, A
    Steinbakk, M
    Urbaskova, P
    Vatopoulos, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) : 145 - 148
  • [10] Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong
    Ling, JM
    Chan, EW
    Lam, AW
    Cheng, AF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) : 3567 - 3573